Johnson & Johnson : How Johnson & Johnson is Working to Create a Healthier Planet
November 30, 2021 at 08:11 am EST
Share
Wonder how much progress Johnson & Johnson is making toward its ambitious goals to help protect the health of our planet?
5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025
Short answer: A lot.
In fact, the company has made considerable strides in transitioning to renewable electricity and is more than halfof the way toward meeting the goal of sourcing 100% of electricity needs at its facilities around the world from renewable sources by 2025.
But what does that mean exactly?
Today, Johnson & Johnson is announcing that it has signed a new power purchase agreement that will bring the company to 100% renewable electricity at its operations in the United States and Canada by 2023.
The new sources of energy will come from a new solar field in the United States with a generation capacity of 55 megawatts or approximately 117,000 megawatt hours of renewable electricity annually-leading to a reduction in greenhouse gas emissions that's the equivalent of taking more than 18,000 cars off the road each year. These add to the existing on- and off-site renewable electricity capacity that powers Johnson & Johnson operations in North America.
With this news, and three new wind and solar agreements the company made in Europe in July, nearly all Johnson & Johnson sites in Europe, the United States and Canada will be powered with 100% renewable electricity by 2023.
The Green Graph: 8 Innovative Ways Johnson & Johnson Is Helping the Environment
The benefit: Generating electricity from low-carbon energy sources decreases emissions of harmful gases, according to the Harvard T.H. Chan School of Public Health, and helps to mitigate climate change, which the World Health Organization recently called the single biggest threat to the health of humanity.
This is all part of how Johnson & Johnson is accelerating its longstanding commitment to help improve the health of our planet through three ambitious goals it plans to meet in the areas of renewable electricity, carbon neutrality for its operations and value chainemissions reductions.
To learn more, check out Johnson & Johnson's full list of Health for Humanity 2025 Goals.
Did you like reading this story? Click the heart to show your love.
21 Health for Humanity Goals for 2025
Learn more about the full list of global citizenship and sustainability goals Johnson & Johnson has set for the next five years.
Read them here
Health & Wellness
Innovation
Health for Humanity
Climate change
Environment
Attachments
Original Link
Original Document
Permalink
Disclaimer
Johnson & Johnson published this content on 30 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2021 13:10:03 UTC.
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
JOHNSON & JOHNSON 
